InvestorsHub Logo
Followers 219
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Re: Den post# 315905

Monday, 05/03/2010 7:13:50 AM

Monday, May 03, 2010 7:13:50 AM

Post# of 648882
OMER $5.90<chart> * Omeros Corp. Reports Addl. Data From Phase 2 Trial Of OMS103HP Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery

Your World Is As BIG as You Make It!!!

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.